Patient Study to Evaluate the Safety and Emollient Performance of Doublebase Once in the Treatment of Psoriasis
NCT: NCT07817394 · NOT_YET_RECRUITING
Brief Summary
This PMCF study is to obtain patient feedback using online questionnaires. There will be no involvement from healthcare professionals (HCPs) or investigator sites. Up to 100 Patients are being recruited by My Health Focus through their website. The study is performed throughout the UK except Northern Ireland with no sites involved in this study. Patients apply directly to participate in the study and the testing and questionnaire responses are completed at home.
Frequently Asked Questions
What is Patient Study to Evaluate the Safety and Emollient Performance of Doublebase Once in the Treatment of Psoriasis?
Patient Study to Evaluate the Safety and Emollient Performance of Doublebase Once in the Treatment of Psoriasis is a clinical trial registered under NCT07817394. Current status: NOT_YET_RECRUITING.
What is the status of NCT07817394?
The current status of NCT07817394 (Patient Study to Evaluate the Safety and Emollient Performance of Doublebase Once in the Treatment of Psoriasis) is: NOT_YET_RECRUITING.
When did Patient Study to Evaluate the Safety and Emollient Performance of Doublebase Once in the Treatment of Psoriasis start?
Patient Study to Evaluate the Safety and Emollient Performance of Doublebase Once in the Treatment of Psoriasis started on 2026-09-21.
Official Source
View on ClinicalTrials.gov →Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.